|
Quintiles Transnational Holdings Inc., through its subsidiary, Quintiles Transnational Corp., provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates in two segments, Product Development and Integrated Healthcare Services. The Product Development segment offers project management and clinical monitoring services, including study design and operational planning, investigator/site recruitment, site and regulatory start up, patient recruitment, clinical monitoring, project management, digital patient, and late phase interventional services for conducting various multi-site trials; and clinical trial support services comprising clinical data management, biostatistical, central laboratories, bioanalytical laboratories, genomic laboratory, cardiac safety and ECG, phase I units, and safety and pharmacovigilance services. It also provides strategic planning and design services; and consulting services, such as product development strategy, regulatory and compliance, and process and IT implementation consulting services. The Integrated Healthcare Services segment offers commercial services consisting of contract sales, market entry/market exit, integrated channel management, patient engagement, market access and commercialization consulting, brand and scientific communication, and medical education services; outcome/observational services that include observational studies, comparative effectiveness studies, and product and disease registry services; and prayer and provider solutions. The company serves for biopharmaceutical companies, as well as other healthcare companies. Quintiles Transnational Holdings Inc. was founded in 1982 and is based in Durham, North Carolina.
|
